The surge in global cancer incidence and the limitations of conventional therapies have created a massive vacuum that mRNA technology is uniquely positioned to fill. One of the major growth drivers is the rising prevalence of solid tumors, which account for a significant portion of cancer deaths. Research into colorectal and pancreatic cancers is particularly promising, as these have...